Greenwich LifeSciences
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 7
- Market Cap
- $183.8M
- Introduction
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
- First Posted Date
- 2022-02-10
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Greenwich LifeSciences, Inc.
- Target Recruit Count
- 598
- Registration Number
- NCT05232916
- Locations
- 🇺🇸
Arizona Oncology Associates - Tucson, Tucson, Arizona, United States
🇺🇸Arizona Oncology Associates - Tucson, Tucson, Arizona, United States
🇺🇸Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center, Fullerton, California, United States